Randomised crossover studies of the bioequivalence of two fenofibrate formulations after administration of a single oral dose in healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 3, 2002, Pages 200-204

  Sonet, Bernard ^a   Vanderbist, Francis ^a   Streel, Bruno ^a   Houin, Georges ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

CAS 49562 28 9; Fenofibrate, bioequivalence, clinical studies; Fenofibric acid; Lidose ; Lipirex

Indexed keywords

FENOFIBRATE; FENOGAL; LIDOSE; LIPIREX;

ABDOMINAL PAIN; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; FLUORESCENCE ANALYSIS; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0036195692     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299880     Document Type: Article

References (9)

1. Évolution, comparée de la mortalité en France et aux USA depuis 1968
2. Traitement des hyperlipidémies
3. Fenofibrate: A review of its pharmacodynamic and pharmacocinetic properties and therapeutic use in dyslipidemia
4. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies
5. Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography